Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
American Heart Journal|May 28, 2018
The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study designAmish N Raval, Thomas D Cook, Henricus J Duckers, et al.JAMA|September 18, 2003
Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trialChristopher M O'Connor, Michael W Dunne, Marc A Pfeffer, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 13, 2020
Carotid Plaque Strain Indices Were Correlated With Cognitive Performance in a Cohort With Advanced Atherosclerosis, and Traditional Doppler Measures Showed no AssociationCarol C Mitchell, Stephanie M Wilbrand, Thomas D Cook, et al.Ultrasound in Medicine & Biology|June 25, 2017
Transcranial Doppler and Microemboli Detection: Relationships to Symptomatic Status and Histopathology FindingsCarol C Mitchell, Stephanie M Wilbrand, Bornali Kundu, et al.Ultrasound in Medicine & Biology|October 11, 2016
Histopathologic Validation of Grayscale Carotid Plaque Characteristics Related to Plaque VulnerabilityCarol C Mitchell, James H Stein, Thomas D Cook, et al.The American Journal of Cardiology|January 9, 2016
Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial)Thomas D Cook, Stephen J Greene, Andreas P Kalogeropoulos, et al.American Heart Journal|August 1, 2006
Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery diseaseDavid Aguilar, Marian R Fisher, Christopher M O'Connor, et al.Family Medicine and Community Health|December 25, 2021
Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit-risk ratio, not ageKyungmann Kim, Charles H Hennekens, Lisa Martinez, et al.International Journal of Cardiology|October 22, 2020
Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohortAmish N Raval, Peter V Johnston, Henricus J Duckers, et al.Science Signaling|December 13, 2018
The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synucleinTaeHee Kim, Suresh L Mehta, Kahlilia C Morris-Blanco, et al.Pageof 5